ASCEND BY NTHRYS
Research Abroad Products

Applied Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Real-Time Genomic Data Integration with EHR Systems
Middleware platform that securely integrates genomic findings directly into electronic health records with automated interpretation rules and clinical decision support alerts. Drives adoption across healthcare networks through improved clinical workflows and patient outcomes, creating subscription revenue and ancillary revenue from data analytics and insights.
Applied Genomics for Rare Disease Diagnosis Click to view more details →
Carrier Screening and Population Risk Stratification Service
Comprehensive genomic testing service that identifies carriers of rare disease mutations and stratifies population risk for preventive medicine and reproductive planning. Expands revenue per patient through tiered testing options, genetic counseling services, and population health contracts with health systems and insurance providers.
Applied Genomics for Rare Disease Diagnosis Click to view more details →
Structural Variant Detection and Clinical Interpretation Tool
Specialized software analyzing large deletions, duplications, inversions, and translocations that traditional sequencing often misses, with automated clinical significance assessment. Captures previously undiagnosed rare disease cases, increasing diagnostic yield and enabling premium pricing for comprehensive genomic analysis services.
Applied Genomics for Rare Disease Diagnosis Click to view more details →
Mitochondrial and Nuclear DNA Variant Analysis Platform
Dedicated platform for detecting and interpreting mitochondrial DNA mutations and nuclear-encoded mitochondrial genes with specialized depth-of-coverage and heteroplasmy analysis. Addresses underdiagnosed rare mitochondrial diseases, creating new revenue streams from specialized testing and supporting development of new gene therapy targets.
Applied Genomics for Rare Disease Diagnosis Click to view more details →
Clinical Laboratory Information System with Genomic Workflow
Integrated LIMS and genomic analysis platform designed specifically for rare disease diagnostic labs with built-in compliance, quality tracking, and reporting automation. Reduces operational overhead by 40% while improving lab throughput and patient safety through standardized protocols, generating licensing revenue and per-sample processing fees.
Applied Genomics for Rare Disease Diagnosis Click to view more details →
Rare Disease Genomic Data Intelligence and Market Intelligence
Data analytics and business intelligence platform aggregating de-identified genomic and clinical data from diagnostic testing to identify rare disease trends, mutation hotspots, and therapeutic opportunities. Generates revenue through data licensing, analytics subscriptions, and pharma partnerships while supporting drug discovery and clinical trial enrollment optimization.
Applied Genomics for Rare Disease Diagnosis Click to view more details →
Tumor Mutational Burden Profiling SaaS Platform
A cloud-based platform that quantifies TMB from sequencing data to predict immunotherapy response and guide treatment selection. This enables oncologists to identify candidates for checkpoint inhibitors, generating recurring subscription revenue and improving clinical outcomes.
Oncology Companion Diagnostic Genomics Platforms Click to view more details →
HLA Typing and Neoantigen Prediction Commercial Tool
An integrated diagnostic tool that identifies patient HLA genotypes and predicts neoantigens for personalized immunotherapy planning and clinical trial matching. This product enables precision oncology workflows and creates revenue through licensing agreements with hospitals and pharmaceutical companies.
Oncology Companion Diagnostic Genomics Platforms Click to view more details →
Liquid Biopsy cfDNA Analysis and Monitoring Platform
A commercial sequencing and analysis service that detects and monitors circulating tumor DNA for early cancer detection and treatment response assessment. This recurring testing service generates high-margin revenue while enabling non-invasive patient surveillance and therapy adjustment.
Oncology Companion Diagnostic Genomics Platforms Click to view more details →
Somatic Cancer Mutation Database and Interpretation Service
A curated, machine-learning-powered database platform that annotates somatic mutations with clinical actionability, drug sensitivity, and resistance mechanisms. This service monetizes through subscription tiers for laboratories, oncology centers, and pharmaceutical companies requiring real-time mutation interpretation.
Oncology Companion Diagnostic Genomics Platforms Click to view more details →
Microsatellite Instability Detection Automated Reporting System
An automated software platform that identifies microsatellite instability (MSI) status from tumor sequencing and generates standardized clinical reports for immunotherapy eligibility. This streamlines laboratory workflows and drives adoption through integration with electronic health records, creating software licensing revenue.
Oncology Companion Diagnostic Genomics Platforms Click to view more details →
BRCA and Hereditary Cancer Risk Stratification Platform
A clinical-grade platform that identifies BRCA1/2 and other hereditary cancer mutations while assessing familial risk and recommending targeted interventions. This diagnostic service generates revenue per test while supporting patient risk management and preventive therapy selection.
Oncology Companion Diagnostic Genomics Platforms Click to view more details →